Publications 2014

  1. Ananworanich J, Bunupuradah T, Apornpong T, et al. Association between lymphocyte and monocyte subsets and cognition in children with HIV. AIDS Res Ther. 2014 Jan 22;11(1):7. doi: 10.1186/1742-6405-11-7.
  2. Avihingsanon A, Ramautarsing RA, Suwanpimolkul G, et al. Ergotism in Thailand caused by increased access to antiretroviral drugs: a global warning. Top Antivir Med. 2014 Jan;21(5):165-8.
  3. IeDea, Collaborations ARTC, Avila D, et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16. doi: 10.1097/QAI.0b013e3182a39979.
  4. Rongkavilit C, Naar-King S, Koken JA, Bunupuradah T, Chen X, Saengcharnchai P, Panthong A, Parsons JT. A feasibility study of motivational interviewing for health risk behaviors among Thai youth livingwith HIV. J Assoc Nurses AIDS Care. 2014 Jan-Feb;25(1):92-7. doi: 10.1016/j.jana.2012.02.008. Epub 2012 Jun 8.
  5. Chokephaibulkit K, Kariminia A, Oberdorfer P, Nallusamy R, Bunupuradah T, Hansudewechakul R, Khanhdung KT, Saphonn V,Kumarasamy N, Lumbiganon P, Viet DC, Kurniati N, Yusoff NK, Razali K, Fong SM, Khanh TH, Wati DK, Sohn AH; for the TREAT Asia Pediatric HIV Observational Database. Characterizing HIV Manifestations and Treatment Outcomes of Perinatally Infected Adolescents in Asia. Pediatr Infect Dis J. 2014 Mar;33(3):291-4. doi: 10.1097/INF.0b013e3182a18223.
  6. Bastiaans DE, Forcat S, Lyall H, et al. Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands. Pediatr Infect Dis J. 2014 Mar;33(3):301-5. doi: 10.1097/INF.0000000000000014.
  7. Rianthavorn P, Kerr SJ, Chiengthong K. Safety of paediatric percutaneous native kidney biopsy and factors predicting bleeding complications. Nephrology (Carlton). 2014 Mar;19(3):143-8. doi: 10.1111/nep.12184.
  8. Bunupuradah T, Panthong A, Kosalaraksa P, et al. Simplifying antiretroviral therapy to lopinavir/ritonavir monotherapy did not improve quality of life and therapy adherence in pretreated HIV-infected children. AIDS Res Hum Retroviruses. 2014 Mar;30(3):260-5. doi: 10.1089/AID.2013.0204. Epub 2013 Dec 21.
  9. Kiertiburanakul S, Boettiger D, Lee MP, et al. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients. J Int AIDS Soc. 2014 Mar 14;17:18804. doi: 10.7448/IAS.17.1.18804. eCollection 2014.
  10. Group ES, Puls R, Amin J, et al. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet. 2014 Apr 26;383(9927):1474-1482. doi: 10.1016/S0140-6736(13)62187-X. Epub 2014 Feb 10.
  11. Hsu DC, Kerr SJ, Thongpaeng P, et al. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy. J Infect. 2014 Apr;68(4):344-54. doi: 10.1016/j.jinf.2013.11.016. Epub 2013 Dec 8.
  12. Ananworanich J, Puthanakit T, Suntarattiwong P, et al. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children. AIDS. 2014 Apr 24;28(7):1015-20. doi: 10.1097/QAD.0000000000000178.
  13. Jiamsakul A, Kumarasamy N, Ditangco R, et al. Factors associated with suboptimal adherence to antiretroviral therapy in Asia. J Int AIDS Soc. 2014 May 16;17:18911. doi: 10.7448/IAS.17.1.18911. eCollection 2014.
  14. Phongsamart W, Hansudewechakul R, Bunupuradah T, et al. Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database. Int J Infect Dis. 2014 May;22:19-24. doi: 10.1016/j.ijid.2013.12.011. Epub 2014 Feb 25.
  15. Phanuphak P, Sirivichayakul S, Jiamsakul A, et al. Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia. J Acquir Immune Defic Syndr. 2014 May 1;66(1):74-9. doi: 10.1097/QAI.0000000000000108.
  16. Intasan J, Bunupuradah T, Vonthanak S, et al. Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial. AIDS Patient Care STDS. 2014 Jun;28(6):296-302. doi: 10.1089/apc.2013.0276.
  17. Tulloch O, Theobald S, Ananworanich J, et al. From transmission to transition: lessons learnt from the Thai paediatric antiretroviral programme. PLoS One. 2014 Jun 3;9(6):e99061. doi: 10.1371/journal.pone.0099061. eCollection 2014.
  18. Seddiki N, Cook L, Hsu DC, et al. Human antigen-specific CD4(+) CD25(+) CD134(+) CD39(+) T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.
    Eur J Immunol. 2014 Jun;44(6):1644-61. doi: 10.1002/eji.201344102. Epub 2014 Apr 29.
  19. Landolt NK, Phanuphak N, Ubolyam S, et al. Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women. J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):e50-2. doi: 10.1097/QAI.0000000000000134.
  20. Hulgan T, Levinson R, Gerschenson M, et al. Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy. AIDS. 2014 Jul 17;28(11):1625-33. doi: 10.1097/QAD.0000000000000297.
  21. Kallianpur KJ, Valcour VG, Lerdlum S, et al. HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy. AIDS. 2014 Jul 17;28(11):1619-24. doi: 10.1097/QAD.0000000000000306.
  22. Prasitsuebsai W, Kariminia A, Puthanakit T, et al. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training Asia pediatric HIV observational database. Pediatr Infect Dis J. 2014 Jul;33(7):747-52. doi: 10.1097/INF.0000000000000226.
  23. Lynfield R, Davey R, Dwyer DE, et al. Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. PLoS One. 2014 Jul 8;9(7):e101785. doi: 10.1371/journal.pone.0101785. eCollection 2014.
  24. Tieu HV, Suntarattiwong P, Puthanakit T, et al. Comparing interferon-gamma release assays to tuberculin skin test in thai children with tuberculosis exposure. PLoS One. 2014 Aug 14;9(8):e105003. doi: 10.1371/journal.pone.0105003. eCollection 2014.
  25. Jiamsakul A, Sungkanuparph S, Law M, et al. HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia. J Int AIDS Soc. 2014 Aug 19;17:19053. doi: 10.7448/IAS.17.1.19053. eCollection 2014.
  26. Achhra AC, Pujari S, Choi JY, et al. Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):e108-11. doi: 10.1097/QAI.0000000000000217.
  27. Avihingsanon A, Jitmitraparp S, Tangkijvanich P, et al. Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels. J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613.
  28. Mandala WL, Ananworanich J, Apornpong T, et al. Control lymphocyte subsets: Can one country’s values serve for another’s?. J Allergy Clin Immunol. 2014 Sep;134(3):759-761.e8. doi: 10.1016/j.jaci.2014.06.030.
  29. Ananworanich J, Avihingsanon A. HIV and Noncommunicable Diseases: The Asian Perspective. J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S99-103. doi: 10.1097/QAI.0000000000000262.
  30. Crane M, Avihingsanon A, Rajasuriar R, et al. Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy. J Infect Dis. 2014 Sep 1;210(5):745-51. doi: 10.1093/infdis/jiu119. Epub 2014 Feb 28.
  31. Boettiger DC, Kerr S, Ditangco R, et al. Trends in First-Line Antiretroviral Therapy in Asia: Results from the TREAT Asia HIV Observational Database. PLoS One. 2014 Sep 3;9(9):e106525. doi: 10.1371/journal.pone.0106525. eCollection 2014.
  32. Kariminia A, Durier N, Jourdain G, et al. Weight as Predictors of Clinical Progression and Treatment Failure: Results From the TREAT Asia Pediatric HIV Observational Database. J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):71-6. doi: 10.1097/QAI.0000000000000227.
  33. Boettiger DC, Saphonn V, Lee MP, et al. A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV Observational Database cohort. J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):e131-3. doi: 10.1097/QAI.0000000000000338.
  34. Bunupuradah T, Techasaensiri C, Keadpudsa S, et al. Pharmacokinetics of Atazanavir/Ritonavir among HIV-Infected Thai Children Concomitantly Taking Tenofovir Disoproxil Fumarate. Pediatr Infect Dis J. 2014 Dec;33(12):e316-9. doi: 10.1097/INF.0000000000000469.
  35. Maek-a-nantawat W, Phanuphak N, Teeratakulpisarn N, et al. Attitudes toward, and interest in, the test-and-treat strategy for HIV prevention among Thai men who have sex with men. AIDS Care. 2014;26(10):1298-302. doi: 10.1080/09540121.2014.911810. Epub 2014 Apr 28.
  36. Giarda P, Avihingsanon A, Sasadeusz J, et al. CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapy. Antivir Ther. 2014;19(4):429-33. doi: 10.3851/IMP2720. Epub 2014 Jan 16.
  37. Avihingsanon A, Apornpong T, Ramautarsing RA, Ubolyam S, Tangkijvanich P, Ananworanich J, Lange JMA, Matthews G, Lewin SR, Ruxrungtham K, HIV-NAT 105 study team. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy. Antivir Ther. 2014;19(1):41-9. doi: 10.3851/IMP2673. Epub 2013 Aug 23.
  38. Bunupuradah T, Bowonwattanuwong C, Jirajariyavej S, et al. HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir. Antivir Ther. 2014;19(6):579-86. doi: 10.3851/IMP2737. Epub 2014 Jan 24.
  39. Sirikum C, Sophonphan J, Chuanjaroen T, et al. HIV disclosure and its effect on treatment outcomes in perinatal HIV-infected Thai children. AIDS Care. 2014;26(9):1144-9. doi: 10.1080/09540121.2014.894614. Epub 2014 Mar 13.
  40. Kerr SJ, Puthanakit T, Vibol U, et al. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care. 2014;26(11):1327-35. doi: 10.1080/09540121.2014.920949. Epub 2014 May 30.
  41. Wattanakul T, Avihingsanon A, Manosuthi W, Punyawudho B. Population pharmacokinetics of nevirapine in Thai HIV-infected patients. Antivir Ther. 2014;19(7):651-60. doi: 10.3851/IMP2741. Epub 2014 Feb 6.